Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 1 - 5 out of 326
Juhás, M & Ecker, G 2026, 'A Proteochemometric Model for Ligands of the SLC5 Transporter Family', Archiv der Pharmazie, vol. 359, no. 1, pp. e70183. https://doi.org/10.1002/ardp.70183
Grillberger, K, Magel, V, Leist, M & Ecker, GF 2025, 'Leveraging Consensus Docking Approaches for Human Mitochondrial Complexes I and III', Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.5c00348
Helmke, PS, Kandler, J, Ilie, S, Gaskin, L & Ecker, GF 2025, 'Data-driven assessment of bioisosteric replacements and their influence on off-target activity profiles', RSC Medicinal Chemistry, vol. 16, no. 12, pp. 6048-6058. https://doi.org/10.1039/d5md00686d
Bloothooft, M, Huang, J, Hamze, M, Houtman, MJC, de Boer, TP, van Hasselt, PM, Ecker, GF, Porcher, C, Medina, I & van der Heyden, MAG 2025, 'Exploring the Cell Biological and Functional Effects of the First Disease Associated KCC1 Genetic Variant', Journal of Cellular Physiology, vol. 240, no. 12, e70124. https://doi.org/10.1002/jcp.70124
Vlasveld, M, van den Berk, L, Piñero, J, Helmke, PS, Ecker, GF, van Rossom, R, Schmidt, BZ, Verfaillie, C, Tassis, K, Callegaro, G, Bouwman, P & van de Water, B 2025, 'A broad kinase inhibitor library live cell imaging screen using liver, kidney and cardiac hiPSC-ICAM1-eGFP reporter lineages identifies liabilities for TNFα pathway modulation', Archives of Toxicology, vol. 100, no. 2, pp. 585-601. https://doi.org/10.1007/s00204-025-04226-6
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding